Post SM - Search Results

1

Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer.

Quintás-Cardama A, Post SM, Solis LM, Xiong S, Yang P, Chen N, Wistuba II, Killary AM, Lozano G. Quintás-Cardama A, et al. Among authors: post sm. J Pathol. 2014 Sep;234(1):108-19. doi: 10.1002/path.4385. Epub 2014 Jul 16. J Pathol. 2014. PMID: 24890125 Free PMC article.

2

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.

Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G. Terzian T, et al. Among authors: post sm. Genes Dev. 2008 May 15;22(10):1337-44. doi: 10.1101/gad.1662908. Genes Dev. 2008. PMID: 18483220 Free PMC article.

3

p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.

Post SM, Quintás-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. Post SM, et al. Oncogene. 2010 Mar 4;29(9):1260-9. doi: 10.1038/onc.2009.423. Epub 2009 Nov 23. Oncogene. 2010. PMID: 19935700 Free PMC article.

4

Closing in on the pathogenesis of the 5q- syndrome.

Post SM, Quintás-Cardama A. Post SM, et al. Expert Rev Anticancer Ther. 2010 May;10(5):655-8. doi: 10.1586/era.10.44. Expert Rev Anticancer Ther. 2010. PMID: 20469997 Review.

5

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.

Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC, Amos CI. Fang S, et al. Among authors: post sm. PLoS One. 2010 May 26;5(5):e10813. doi: 10.1371/journal.pone.0010813. PLoS One. 2010. PMID: 20520810 Free PMC article.

6

Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, Post SM, Lozano G. Xiong S, et al. Among authors: post sm. Cancer Res. 2010 Sep 15;70(18):7148-54. doi: 10.1158/0008-5472.CAN-10-1457. Epub 2010 Aug 24. Cancer Res. 2010. PMID: 20736370 Free PMC article.

7

You can win by losing: p53 mutations in rhabdomyosarcomas.

Post SM, Lozano G. Post SM, et al. J Pathol. 2010 Oct;222(2):124-8. doi: 10.1002/path.2757. J Pathol. 2010. PMID: 20821751

8

A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.

Post SM, Quintás-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, Lozano G. Post SM, et al. Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.

9

Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo.

Jackson JG, Post SM, Lozano G. Jackson JG, et al. Among authors: post sm. J Pathol. 2011 Jan;223(2):127-36. doi: 10.1002/path.2783. Epub 2010 Oct 18. J Pathol. 2011. PMID: 20957626 Review.

10

Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Post SM, Pant V, Abbas H, Quintás-Cardama A. Post SM, et al. Oncotarget. 2010 Jul;1(3):168-174. doi: 10.18632/oncotarget.123. Oncotarget. 2010. PMID: 21301048 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters